A RECENT study out of Canada
and the UK and published
in Therapeutic Advances in
Gastroenterology has summarised
that “there is rapidly increasing
epidemiological and strong
experimental evidence, suggesting
a role for vitamin D in inflammatory
bowel disease (IBD) and colorectal
cancer (CRC).”
The paper said that “it is clear
that vitamin D potentially has
potent immunomodulatory actions
on the T-cell-mediated processes
implicated in the pathogenesis of
IBD, both at DC and T-cell level.”
The researchers called for more
study on the matter especially in
the form of clinical studies.
CLICK HERE to read the paper.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Feb 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Feb 14
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.